Literature DB >> 28414770

Correction: Efficient and robust differentiation of endothelial cells from human induced pluripotent stem cells via lineage control with VEGF and cyclic AMP.

Takeshi Ikuno, Hidetoshi Masumoto, Kohei Yamamizu, Miki Yoshioka, Kenji Minakata, Tadashi Ikeda, Ryuzo Sakata, Jun K Yamashita.   

Abstract

[This corrects the article DOI: 10.1371/journal.pone.0173271.].

Entities:  

Year:  2017        PMID: 28414770      PMCID: PMC5393897          DOI: 10.1371/journal.pone.0176238

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


The lines labeled “vehicle” and “cAMP+VEGF” are incorrectly switched in Fig 2b and 2c. Please see the corrected Fig 2 here.
Fig 2

Time course of endothelial cell and pre-endothelial cell marker.

(a) Representative expression time course of VE-cadherin (VECad) and CD31 under stimulation method (VEGF+cAMP) or vehicle without VEGF and cAMP by FACS. (b) Time course of VE-Cadherin-positive cell ratio in two groups. (c) Yield of VE-Cadherin positive endothelial cells per 1cm2 in two groups. (d) Time course of total cell counts in two groups. (e) Representative expression time course of VEGF receptor 2 (VEGFR2) and VE-cadherin in stimulation method (VEGF+cAMP) or vehicle without cAMP and VEGF. Arrows: non-responder cells to VEGF and cAMP stimulation.

Time course of endothelial cell and pre-endothelial cell marker.

(a) Representative expression time course of VE-cadherin (VECad) and CD31 under stimulation method (VEGF+cAMP) or vehicle without VEGF and cAMP by FACS. (b) Time course of VE-Cadherin-positive cell ratio in two groups. (c) Yield of VE-Cadherin positive endothelial cells per 1cm2 in two groups. (d) Time course of total cell counts in two groups. (e) Representative expression time course of VEGF receptor 2 (VEGFR2) and VE-cadherin in stimulation method (VEGF+cAMP) or vehicle without cAMP and VEGF. Arrows: non-responder cells to VEGF and cAMP stimulation.
  1 in total

1.  Efficient and robust differentiation of endothelial cells from human induced pluripotent stem cells via lineage control with VEGF and cyclic AMP.

Authors:  Takeshi Ikuno; Hidetoshi Masumoto; Kohei Yamamizu; Miki Yoshioka; Kenji Minakata; Tadashi Ikeda; Ryuzo Sakata; Jun K Yamashita
Journal:  PLoS One       Date:  2017-03-13       Impact factor: 3.240

  1 in total
  4 in total

Review 1.  HiPS-Cardiac Trilineage Cell Generation and Transplantation: a Novel Therapy for Myocardial Infarction.

Authors:  Ampadu O Jackson; Huifang Tang; Kai Yin
Journal:  J Cardiovasc Transl Res       Date:  2019-05-31       Impact factor: 4.132

2.  High-efficient serum-free differentiation of endothelial cells from human iPS cells.

Authors:  Sarkawt Hamad; Daniel Derichsweiler; John Antonydas Gaspar; Konrad Brockmeier; Jürgen Hescheler; Agapios Sachinidis; Kurt Paul Pfannkuche
Journal:  Stem Cell Res Ther       Date:  2022-06-11       Impact factor: 8.079

Review 3.  Present State and Future Perspectives of Prostaglandins as a Differentiation Factor in Motor Neurons.

Authors:  Hiroshi Nango; Yasuhiro Kosuge
Journal:  Cell Mol Neurobiol       Date:  2021-05-25       Impact factor: 4.231

4.  The prostaglandin H2 analog U-46619 improves the differentiation efficiency of human induced pluripotent stem cells into endothelial cells by activating both p38MAPK and ERK1/2 signaling pathways.

Authors:  Liping Su; Xiaocen Kong; Szeyun Lim; Szejie Loo; Shihua Tan; Kiankeong Poh; James Dutton; Colin Stewart; Stuart Cook; Xiaofei Su; Jianhua Ma; Jianyi Zhang; Lei Ye
Journal:  Stem Cell Res Ther       Date:  2018-11-15       Impact factor: 6.832

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.